News Celyad Oncology SA

Equities

CYAD

BE0974260896

Market Closed - Euronext Bruxelles Other stock markets 11:38:12 2024-04-19 am EDT			5-day change	1st Jan Change
0.3395 ^EUR	+4.14%		+6.09%	-12.95%

Apr. 04	Celyad Oncology SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 09	Celyad Oncology Seeks Termination of Reporting Obligations to US SEC	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Celyad Oncology reports full year 2023 financial results and recent business highlights	Apr. 05	AQ
Celyad Oncology : Report of the Statutory Auditor on the Consolidated Annual Account 2023 ENG	Apr. 05	PU
Celyad Oncology SA Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 04	CI
Celyad Oncology Seeks Termination of Reporting Obligations to US SEC	Feb. 09	MT
Celyad Oncology provides fourth quarter 2023 business update and 2024 outlook	Jan. 16	AQ
Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)	Dec. 20	AQ
Celyad Oncology CEO Resigns	Dec. 05	MT
Celyad Oncology CEO Steps Down for Personal Reasons	Dec. 04	MT
Celyad announces management change	Dec. 04	AQ
Celyad Oncology SA Announces Executive Change	Dec. 04	CI
Celyad Oncology Sa Announces Executive Change	Dec. 04	CI
Celyad Oncology : announces management change	Dec. 01	PU
Celyad Oncology : reports third quarter 2023 financial results and recent business highlights - Form 6-K	Nov. 24	PU
Celyad Oncology SA - Publication of a transparency notification received from Fortress Investment Group LLC	Nov. 22	AQ
Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)	Nov. 21	AQ
Celyad Oncology : CONVENING LETTER TO THE EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS OF 22 DECEMBER 2023 - Form 6-K	Nov. 21	PU
Celyad Oncology SA announced that it has received ?9.794 million in funding from CFIP CLYD (UK) Limited, Fortress Investment Group LLC, Tolefi S.A.	Nov. 13	CI
Celyad Oncology reports third quarter 2023 financial results and recent business highlights	Nov. 09	AQ
Celyad Oncology : CONVENING LETTER TO THE EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS OF 14 NOVEMBER 2023 - Form 6-K	23-10-27	PU
Celyad Oncology to Cancel American Depository Receipt Program in October	23-09-26	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Celyad Oncology SA

Equities

CYAD

BE0974260896

Summary

Filters